Beijing Airdoc Technology Co (HKSE:02251) Operating Income : HK$-201.7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Operating Income?

Beijing Airdoc Technology Co's Operating Income for the six months ended in Dec. 2023 was HK$-103.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-201.7 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Beijing Airdoc Technology Co's Operating Income for the six months ended in Dec. 2023 was HK$-103.5 Mil. Beijing Airdoc Technology Co's Revenue for the six months ended in Dec. 2023 was HK$132.9 Mil. Therefore, Beijing Airdoc Technology Co's Operating Margin % for the quarter that ended in Dec. 2023 was -77.89%.

Beijing Airdoc Technology Co's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Beijing Airdoc Technology Co's annualized ROC % for the quarter that ended in Dec. 2023 was -36.39%. Beijing Airdoc Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -218.41%.

Beijing Airdoc Technology Co Operating Income Historical Data

The historical data trend for Beijing Airdoc Technology Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Operating Income Chart

Beijing Airdoc Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Income

-57.93

-67.17

-172.37

-261.68

-201.70

Beijing Airdoc Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Income	Get a 7-Day Free Trial				-122.15	-149.89	-118.89	-98.23	-103.47

Beijing Airdoc Technology Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-201.7 Mil.

Beijing Airdoc Technology Co (HKSE:02251) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Beijing Airdoc Technology Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-206.948 * ( 1 - 0.66% )	/	( (532.084	+	597.86)	/ 2 )
=	-205.5821432	/	564.972
=	-36.39 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1939.808	-	44.868	-	( 1362.856	-	max(0, 98.727	-	1540.941	+	1362.856	))
=	532.084

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1842.921	-	47.225	-	( 1197.836	-	max(0, 120.575	-	1402.145	+	1197.836	))
=	597.86

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Beijing Airdoc Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-229.824	/	( ( (32.606 + max(58.051, 0))	+	(31.113 + max(88.686, 0)) )	/	2 )
=	-229.824	/	( ( 90.657	+	119.799 )	/	2 )
=	-229.824	/	105.228
=	-218.41 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(88.344	+	59.69	+	0)	-	(44.868	+	0	+	45.115)
=	58.051

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(87.109	+	43.898	+	68.823)	-	(47.225	+	0	+	63.919)
=	88.686

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Beijing Airdoc Technology Co's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %	=	Operating Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-103.474	/	132.853
	=	-77.89 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Beijing Airdoc Technology Co Operating Income Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Airdoc Technology Co (HKSE:02251) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN

Website

https://www.airdoc.com

Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.

Executives

Mialkos Tomasz Jakub	2101 Beneficial owner
Zhang Dalei	2501 Other
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd.	2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Chen Mingqiang	2501 Other
Gao Fei	2501 Other
Niagara Falls Holding Limited	2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines